A clinical study on canines proves that Can-C Cataract Eye Drop is safe and effective for dogs

The control study involved 30 dogs or 60 eyes, which received a topical of Can-C 1% N-acetylcarnosine eye drops for cataracts twice daily. The study found that there was a significant improvement on the animal’s visual behavior in just 2 weeks of treatment. The reversal of the cataracts starts from the cataract periphery, which is then followed by an increased lens transparency.

96% of the canine eyes dropped with the Can-C N-acetylcarnosie cataract treatment drops showed significant improvements, even on dogs with both ripe and immature cataracts.

According to an excerpt from Dr. Mark Babizhayev’s published article “Treatment of Age-Related Cataract in Canines” in the 2006 volume of the Current Drug Therapy Journal, Can-C N-Aceteylcarnosine is highly recommended for canine cataract treatment.

Dr. Babizhayev used Can-C eye drops to Skeeter, his 15 year old mini pinscher, for a period of one year, and the canine’s cataracts diminished. He came to the conclusion that the cataract eye drops that are usually used by humans are also a scientific miracle for dogs. According to Dr. Babizhayev’s observations, Can-C has prevented Skeeter from totally going blind, in fact, it has improved his aging experience.

The testing of different anti-glycation products for almost 10 years led a research team from Russia to develop the n-alpha-acetylcanosine as an excellent delivery system for the natural eye anti-oxidant L-carnosine. After the laboratory testing passed, the next stage was to test N-acetyl-carnosine Can-C eye drops in the eyes of rabbits and dogs.

These studies showed remarkable and immediate results in improving the clarity and vision for the animals that were part of the study. There were no side effects noted and the positive effects were sustainable. These positive results led to studies being continued in human beings.

The treatment of cataracts in rabbits and dogs has been extensive and the effectiveness of using N-acetylcarnosine for age-related cataracts has been solidified.

These days, many dog owners are now using the product to address their pets’ ocular cataract condition, and this is now a standard treatment by many veterinarians as well. The results produced from the Russian trials were very impressive and presented no side effects. Dr. Babizhayev noted that Can-C seems to work better in canines than in humans. Although the dosage for dogs has not yet been clearly defined, the human dosage of 3 to 4 drops per eye appears to work for canines.

When using Can-C on your pet, it is highly recommended that you check with your veterinarian first.

All Wise Choice Medicine customers who follow the instructions for the product usage will see significant improvements in their dog’s cataract condition. The results level may vary depending on the maturity of the cataract before the treatment. Also, cataracts that had been induced by injury may take a longer period of time to respond to the product. It is critical to apply the product consistently as it can mean the difference between minimal results and excellent results.